Fundraising Fox
Ronatherapeutics
Shanghai, CN · 3 known investors
Find your way into Ronatherapeutics
Sign up to see every warm intro you have to Ronatherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ronatherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rona Therapeutics develops siRNA-based therapeutics using its GAIA platform to target metabolic and cardiovascular conditions including hypertriglyceridemia, obesity, ASCVD, and MASH. Its pipeline includes APOC3, INHBE, PCSK9-Lp(a), and angiotensinogen-targeting candidates for patients with cardiovascular and metabolic diseases.
Founders & leadership
Investors · 3
.jpeg){kind=logo}
Frequently asked questions
- What does Ronatherapeutics do?
- Rona Therapeutics develops siRNA-based therapeutics using its GAIA platform to target metabolic and cardiovascular conditions including hypertriglyceridemia, obesity, ASCVD, and MASH. Its pipeline includes APOC3, INHBE, PCSK9-Lp(a), and angiotensinogen-targeting candidates for patients with cardiovascular and metabolic diseases.
- Who founded Ronatherapeutics?
- Ronatherapeutics was founded by Jinyu Huang, Stella Shi.
- Who are Ronatherapeutics's investors?
- Ronatherapeutics's investors include B Capital Group, LAV, Lilly Asia Ventures.
- Where is Ronatherapeutics headquartered?
- Ronatherapeutics is headquartered in Shanghai, CN.